About

Tarsus Pharmaceuticals, Inc. focuses on developing innovative therapeutics for various eye conditions, including an FDA-approved treatment for Demodex blepharitis called XDEMVY™, utilizing advanced pharmaceutical formulations and scientific research to address high unmet medical needs in eye care. The main technologies used in their product include advanced pharmaceutical formulations and scientific research.